Key result
Serum POSTN levels greater than 2033 pg/mL demonstrated excellent diagnostic performance (AUC 0.95) for detecting advanced intervertebral disc degeneration.
Why the study?
The pathophysiology of intervertebral disc degeneration remains incompletely elucidated, and identifying key proteins driving disease progression is crucial for developing targeted therapies.
Does POSTN inhibition alleviate intervertebral disc degeneration in preclinical models?
Does POSTN inhibition alleviate intervertebral disc degeneration in preclinical models?
Effect estimate: AUC 0.95
p-value: p=<0.05
POSTN serves as a potential diagnostic biomarker for advanced intervertebral disc degeneration, and its targeted inhibition alleviates disease progression by restoring autophagy in preclinical models.
POSTN may serve as an IDD biomarker; leaves open causal or therapeutic roles pending validation.
The pathophysiology of intervertebral disc degeneration (IDD), a condition associated with significant morbidity, remains incompletely elucidated. Identification of key proteins that drive IDD progression is crucial for developing effective strategies to mitigate disease advancement. In this study, we discovered that periostin (POSTN) play an important role in IDD through the bioinformatic analysis, and confirmed its presentation in patient nucleus pulposus (NP) tissues and serum samples. Additionally, the serum POSTN level is positively correlated with IDD. To further investigate the functions of POSTN, the nucleus pulposus cells (NPCs) were isolated and stimulated with 10 ng/mL tumor necrosis factor-α (TNF-α) for 48 h as the in vitro disease model. And evaluated by qPCR, western blots, immunofluorescence (IF) staining, transmission electron microscopy and transcriptome sequencing. The data demonstrated that POSTN promotes IDD by inhibiting autophagy in NPCs. The results were validated in vivo through the caudal vertebra needle puncture model of Sprague-Dawley (SD) rats, with X-ray, magnetic resonance imaging (MRI), hematoxylin-eosin (H&E) staining, safranin O-fast green staining, and immunohistochemical staining. In summary, this study demonstrated that POSTN has potential to be a diagnostic marker and therapeutic target for IDD treatment.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied Intervertebral disc degeneration (n=31). Periostin (POSTN) vs. Lower grade degeneration (Pfirrmann grades 2-3) was evaluated on Detection of advanced intervertebral disc degeneration (Pfirrmann grade ≥ 4) (AUC 0.95, p=<0.05). Serum POSTN levels greater than 2033 pg/mL demonstrated excellent diagnostic performance (AUC 0.95) for detecting advanced intervertebral disc degeneration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: